Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
European Patent
20774960.7
Filed on 2020-09-17
20774960.7
Filed on 2020-09-17
Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
US Application 17/753,706
Filed on 2020-09-17
Filed on 2020-09-17
Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
South Korea
10-2022-7008878
Filed on 2020-09-17
10-2022-7008878
Filed on 2020-09-17
Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
Brazil
BR112022004861
Filed on 2020-09-17
BR112022004861
Filed on 2020-09-17
Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
China
202080065098.2
Filed on 2020-09-17
202080065098.2
Filed on 2020-09-17
Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
Australia
2020349353
Filed on 2020-09-17
2020349353
Filed on 2020-09-17
Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
Japan
2022-517823
Filed on 2020-09-17
2022-517823
Filed on 2020-09-17
Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
Patent Cooperation Treaty
PCT/EP2020/075948
Filed on 2020-09-17
PCT/EP2020/075948
Filed on 2020-09-17